FDA Exploring ‘Flexibilities’ In Marijuana Scheduling Review, But Top Official Says DEA Has ‘Final Word’: “That is a very high priority that the secretary of HHS is very interested in.” $TLRY etc https://t.co/fwRK73Jgli
FDA Exploring ‘Flexibilities’ In Marijuana Scheduling Review, But Top Official Says DEA Has ‘Final Word’: “That is a very high priority that the secretary of HHS is very interested in.” $TLRY etc https://t.co/fwRK73Jgli